| Jiang, Yang |
| Completed | N/A | 4 | US | Neurofeedback, biofeedback | VA Office of Research and Development | Mild Cognitive Impairment | 09/24 | 09/24 | | |
NCT06778473: Intradermal Acupuncture and Self-rehabilitation Program in Patients With Severe Bell's Palsy |
|
|
| Not yet recruiting | N/A | 552 | RoW | Active Intradermal Acupuncture, Sham Intradermal Acupuncture, Guided self-rehabilitation management program, Health Education | Zhangjiagang First People's Hospital | Bell Palsy | 09/29 | 12/29 | | |
| Wu, Qiuyi |
NCT05719688: Evaluate the Safety and Efficacy of Thrombectomy System in the Intravascular Treatment of Acute Ischemic Stroke |
|
|
| Recruiting | N/A | 200 | RoW | Mechanical thrombectomy | Suzhou Hengruihongyuan Medical Technology Co. LTD | Acute Ischemic Stroke | 12/23 | 12/24 | | |
| ZHOU, Liang |
NCT05042375: A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer |
|
|
| Recruiting | 3 | 450 | RoW | camrelizumab + famitinib, pembrolizumab, camrelizumab | Jiangsu HengRui Medicine Co., Ltd. | Non-small Cell Lung Cancer | 12/23 | 12/25 | | |
NCT04156698: Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma |
|
|
| Active, not recruiting | 2 | 51 | RoW | Docetaxel, Docetaxel (domestic), Cisplatin, chemotherapy drug, Capecitabine, Camrelizumab, Anti-PD-1 Antibody (Jiangsu Hengrui) | Eye & ENT Hospital of Fudan University | Hypopharyngeal Carcinoma, Immunotherapy, Chemotherapy | 04/23 | 01/26 | | |
NCT05416775: Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer |
|
|
| Recruiting | 1/2 | 168 | RoW | SHR-8068；Adebrelimab, SHR-8068；adebrelimab and platinum-based chemotherapy, Adebrelimab；platinum-based chemotherapy | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Advanced Non-small Cell Lung Cancer | 06/26 | 06/26 | | |
